Showing 681-690 of 2448 results for "".
The Effects of Obesity on Brain Structure and Size
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-effects-of-obesity-on-brain-structure-and-size/30714/An examination of both the pathophysiology of the link between obesity and brain injury, and available strategies that may reverse it.Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.Diagnosis and Management of Neurodegenerative Atypical Parkinsonism
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-neurodegenerative-atypical-parkinsonism/30455/EMG and Nerve Conduction Studies in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/emg-and-nerve-conduction-studies-in-clinical-practice/30863/Electrodiagnostic studies are helpful in evaluating weakness, muscle wasting, and sensory symptoms. More specific questions may allow more detailed and directed conclusions.Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.The Approval of PFO Closure in the United States
https://practicalneurology.com/diseases-diagnoses/stroke/the-approval-of-pfo-closure-in-the-united-states/30295/A look back at the long road to FDA approval and the implications on patient care options going forward.Update on Treatment Options for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/update-on-treatment-options-for-dementia/30528/Although there is no treatment to correct the pathological process that leads to AD, there is a large window of opportunity to treat this condition before it becomes clinically evident.March 2016 Case Challenge: A Woman with Muscle Stiffness
https://practicalneurology.com/diseases-diagnoses/neuromuscular/march-2016-case-challenge-a-woman-with-muscle-sti/31088/A 34-year-old woman presented with muscle stiffness worsened by cold temperature and stress. The demonstrated sign can be seen in: 1. Paramyotonia congenita (PMC) 2. Myotonia congenita (MC) 3. Hypokalemic periodic paralysis (HypoKPP) 4. Polymyositis 5. Oculopharyngeal muscular dystrophy The correcPOINT-COUNTERPOINT: Natalizumab Extended-Interval Dosing
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/point-counterpoint-natalizumab-extended-interval-dosing/30124/Optimism vs caution for using extended-interval dosing to prevent progressive multifocal leukoencephalopathy.Reproductive Issues for Patients With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/reproductive-issues-for-patients-with-multiple-sclerosis/30215/The prototypic patient with multiple sclerosis is a young woman of childbearing age, which makes reproductive issues extremely important.